Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 September 2020 | Story Nitha Ramnath | Photo Supplied
SWSA represented by Mariné du Toit (left) and Lyshea Mapaike(right) at the handover of the funds raised

Sunflower Children’s Hospice, situated on the ground floor of the National District Hospital, is a non-profit organisation that provides care and compassion for all children with life-threatening and life-limiting conditions. As far as possible, the hospice aims to keep children within their families and communities, with relevant supervision and support.  However, the hospice is also a permanent residence to many children.

At Sunflower Children’s Hospice, children and their families are provided with:
• palliative care, including pain and symptom management;
• quality of life;
• relief of suffering;
• support for child and family/guardians;
• developmental stimulation;
• support during the bereavement period;
• dignity in death;
• community participation; and
• relevant training.

Due to limited funds, the hospice experiences many financial challenges, which motivated the Social Work Student Association (SWSA) to become involved. Their involvement led to the establishment of the ‘#Adoptaflower’ project by raising funds for the organisation and getting more Social Work students to spend time with the children, as they do not have enough caregivers at the house to give them the special personal attention that they need.  This project was spearheaded by Mariné du Toit, Portfolio Head: Community Upliftment of the SWSA. 

The fundraising initiative collected R1 300 from selling raffle tickets to the university community.  Due to COVID-19 and the lockdown period, it became impossible to proceed with the intention of the Social Work students to spend more time with the children.  

Besides Social Work students not being able to proceed with their intention of interacting more closely with the children concerned, the lockdown unfortunately also affected it negatively in other areas.  The hospice needs assistance with clothes, toiletries, and groceries. Sunflower House therefore needs funds and sponsors to continue providing services to so many children in need of care and support. For more information regarding public involvement, 051 448 3813 is the number to call. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept